期刊文献+

FibroTouch联合超声和CT检查诊断高原地区非酒精性脂肪性肝病临床应用研究 被引量:2

Clinical application of FibroTouchand abdominal color ultrasound and computed tomography in diagnosis of individuals with nonalcoholic fatty liver disease in plateau regions
下载PDF
导出
摘要 目的评价FibroTouch(FT)联合超声和CT检查诊断青海高原地区非酒精性脂肪性肝病(NAFLD)患者的临床应用价值。方法2018年8月~2019年5月青海省人民医院消化科住院的非酒精性脂肪性肝病患者343例,所有人员同时接受FT、腹部超声和腹部CT检查,分析任意检查对NAFLD的检出率,并分析FT相对于腹部超声和CT诊断NAFLD的灵敏度、特异度和受试者工作特征曲线下面积(AUROC),以Kappa值评价FT与这两种方法诊断的一致性,分析FT单独和联合这两种方法诊断NAFLD的检出率。结果FT诊断本组人群NAFLD的检出率为63.9%,腹部超声诊断检出率为40.2%,腹部CT检出率为26.2%;相对于腹部超声诊断NAFLD,FT检查的灵敏度为82.6%,特异度为48.8%,AUROC为0.657(95%CI:0.610~0.704);相对于腹部CT诊断NAFLD,FT检查诊断的灵敏度为88.9%,特异度为45.1%,AUROC为0.670(95%CI:0.624~0.715);FT检查与腹部超声检查诊断NAFLD的总体一致性为62.4%,Kappa系数为0.29,说明两者诊断的一致性较差;FT检查与腹部CT检查诊断的总体一致性为56.6%,Kappa系数为0.23,两者诊断的一致性也较差;三者联合检查均诊断为NAFLD患者247例,其中FT检查、腹部超声和腹部CT检查的单独检出率分别为88.7%、55.9%和36.4%,联合FibroTouch和腹部超声诊断或联合FT和腹部CT诊断将检出率分别提高到98.4%和92.7%。结论使用FT检查、腹部超声和腹部CT检查诊断NAFLD的一致性较差,联合FT和腹部超声诊断、联合FT和腹部CT诊断能进一步提高高原地区人群NAFLD的检出率。 Objective The aim of this study was to evaluate the clinical application of FibroTouch(FT)in combination with abdominal color ultrasound and computed tomography(CT)in diagnosis of individuals with nonalcoholic fatty liver disease in plateau regions.Methods A total of 343 persons with nonalcoholic fatty liver disease(NAFLD)were enrolled in the Department of Gastroenterology in the Qinghai Provincial People's Hospital between August 2018 and May 2019.The NAFLD was diagnosed by the examination of FT,abdominal color ultrasound,or CT.The diagnostic sensitivity,consistency,and diagnosis rate of FT relative to ultrasound or CT examination were analyzed by AUROC and Kappa value.Results The diagnosed rate of NAFLD by FT,ultrasound and CT examination were 63.9%,40.2%and 26.2%,respectively,in our series;the diagnosis sensitivity and specificity of FT relative to ultrasoundex amination were 82.6%and 48.8%(AUROC=0.657,95%CI:0.610-0.704),and those relative to CT examination were 88.9%and 45.1%(AUROC=0.670,95%CI:0.624-0.715);the diagnostic results of FT had a lower consistency with both ultrasound or CT diagnosis by 62.4%(Kappa coefficient=0.29)and 56.6%(Kappa coefficient=0.23),respectively;the diagnostic rates of FT,ultrasound and CT examination were 88.7%,55.9%and 36.3%,respectively;the diagnostic rates were raised to 98.4%and 92.7 when the FT combined with ultrasound examination or CT examination,respectively.Conclusions There is a lower consistency between FT and ultrasound or CT examination in diagnosis of NAFLD,while the diagnostic rate of NAFLD could be improved by FT combined with ultrasound or CT examination in persons in plateau regions.
作者 李萍英 李娟 谢守珍 杨永耿 陆伦根 Li Pingying;Li Juan;Xie Shouzhen(Department of Gastroenterology,Provincial People’s Hospital,Xining 810007,Qinghai Province,China)
出处 《实用肝脏病杂志》 CAS 2020年第6期817-820,共4页 Journal of Practical Hepatology
基金 青海省卫生与健康委员会指导性研究项目(编号:(2019-wjzdx-34))。
关键词 非酒精性脂肪性肝病 FibroTouch 高原地区 诊断 Nonalcoholic fatty liver diseases FibroTouch Plateau regions Diagonsis
  • 相关文献

参考文献6

二级参考文献37

  • 1中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:384
  • 2袁利超,邵金华,郝美娜,李程,王贵萍,王泰龄,罗建文,白净,马安林.肝脏硬度测定仪FibroTouch与FibroScan和肝脏病理分期的相关性[J].中华肝脏病杂志,2014,22(6). 被引量:44
  • 3Liaw YF, Leung N, Guan R, et al. Asian-Pacific on the management of chronic hepatitis B: a 2005update[J]. Liver Int, 2005, 25(3): 472 - 489.
  • 4Sung JJ, Tsoi KK, Wong VW, et al. Meta-analysis: treatment of hepatitisB infection reduces risk of hepatocellular carcinoma[J]. Aliment PharmacolTher, 2008, 28 (9): 1067 - 1077.
  • 5Mok TS, Yeo W, Yu S, et al. An intensive surveillance programdetected a high incidence of hepatocellular carcinoma among hepatitisB virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results[J]. J Clin Oncol, 2005, 23 (31): 8041-8047.
  • 6Wong GL, Wong VW, Tan GM, et al. Surveillance programmeforhepatocellular carcinoma improves the survival of patients withchronic viral hepatitis[J]. Liver Int, 2008, 28 (1): 79-87.
  • 7Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study[J]. Lancet, 2001, 357(9262): 1069-1075.
  • 8Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study[J]. Gastroenterology, 2004, 127(6): 1704-1713.
  • 9Zeng MD, Lu LG, Mao YM, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model[J]. Hepatulogy, 2005, 42(6): 1437-1445.
  • 10Du D, Zhu X, Kuno A, et al. Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels[J]. Clin Chim Acta, 2012, 21(21-22): 1796-1799.

共引文献1687

同被引文献20

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部